Clinical Trials Logo

Clinical Trial Summary

This is a prospective, observational study with a primary objective of determining the incidence of non-severe and severe COVID-19, including MIS-C, among eligible children who are diagnosed with COVID-19 and consent (or assent) to collection of data on risk factors using a unique direct-to-participant, direct-to-family, and direct-to-community approach. Secondary and exploratory objectives include risk factors of severe disease and quality of life (QoL).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04757831
Study type Observational
Source Duke University
Contact
Status Withdrawn
Phase
Start date October 15, 2021
Completion date February 15, 2026